Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.

Source:http://linkedlifedata.com/resource/pubmed/id/20207541

Bioorg. Med. Chem. Lett. 2010 Apr 1 20 7 2106-10

Download in:

View as

General Info

PMID
20207541